#ExistInterpData>Methodology: Qualitative Liquid Chromatography-Time-of-Flight Mass Spectrometry
The absence of expected drug(s) and/or drug metabolite(s) may indicate non-compliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, or limitations of testing. The concentration must be greater than or equal to the cutoff to be reported as present. If specific drug concentrations are required, contact the laboratory within two weeks of specimen collection to request confirmation and quantification by a second analytical technique.
For medical purposes only; not valid for forensic use.
Drugs covered and range of cutoff concentrations. Note that some drugs are identified based on the presence of unique drug metabolites not listed below.
See Compliance Statement B: www.aruplab.com/CS
||Range of Cutoff Concentrations
buprenorphine, codeine, dihydrocodeine, fentanyl, heroin, hydrocodone, hydromorphone, meperidine, methadone, morphine, naloxone, naltrexone, oxycodone, oxymorphone, propoxyphene, tapentadol, tramadol
amphetamine, cocaine, methamphetamine, MDMA (Ecstasy), MDEA (Eve), MDA, methylphenidate, phentermine
alprazolam, amobarbital, butalbital, chlordiazepoxide, clonazepam, diazepam, flurazepam, flunitrazepam, lorazepam, midazolam, nordiazepam, oxazepam, pentobarbital, phenobarbital, secobarbital, temazepam, triazolam, zolpidem
||80100 x2 (HCPCS: G0431).
||Pain Management (Drug Screen, Targeted, Serum or Plasma)